Biotech redeveloping abandoned drugs for non-small cell lung cancer.
Industry: Health Care
First Day Return: -0.3%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 04/16/2020 |
Offer Price | $15.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 1.8 |
Deal Size ($mm) | $26 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 06/10/2020 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $26 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Dallas, TX, United States |
Founded | 2013 |
Employees at IPO | 7 |
Website www.lanternpharma.com |